The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Pharmacology · Pharmacokinetics · continued

Peak-to-trough ratio at steady state for a weekly agent — the long version posts 61–62

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

K
KnowltonTL326 Jul 2026#61
SA
s.achebeTL227 Jul 2026#62

Post #60 is right about the mechanism and I think understates the practical bit.

The thing about Peak-to-trough ratio that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.

3 likes 1d

Suggested topics

TopicParticipantsRepliesViewsActivity
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
MSPMAICLAP+104 110 16k 2d
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the kinetics rather than the pharmacology,…
EDRFCHLIAK+110 126 14k 4mo
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. A narrow question about Albumin binding,…
BRIJVPYR+7 11 31k 17mo
Coming back to: Half-life, steady state, and accumulation worked through
On the subject in the title: Half-life, steady state, and accumulation worked through Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
CRHKASMISC+14 18 15k 3mo
Albumin binding and how it produces a long half-life
Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. A narrow question about albumin binding, deliberately narrow, because the broad…
SDDMTBBTAM+38 44 6.6k 14mo

Related topics — sharing the tags semaglutide, missed dose, tirzepatide

TopicParticipantsRepliesViewsActivity
Why most self-reports here are not experiments, and that is fine
Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. A question about what a single-person experiment can…
SBSKGF 2 46k 11mo
Pen dose counters: what a click does and does not guarantee
On the subject in the title: Pen dose counters: what a click does and does not guarantee Working notes rather than a conclusion. Pen dose counters — I have the observation and I do not trust my interpretation…
PNERBAKED+116 122 1.6k 8mo
[2026 update] How much of the diluent volume the powder itself displaces
The question in the title: How much of the diluent volume the powder itself displaces I will give what I have already checked below so nobody repeats it. Writing this out with the numbers in it, because…
ECFWCLRFDS+89 100 3.2k 8mo
Storing a pen in use versus a pen unopened
Storing a pen in use versus a pen unopened Writing it up because I had to work it out twice and would rather nobody else did. Proposing that storing a pen deserves a maintained page rather than a recurring…
ARDSYAJWTK+14 18 13k 14mo
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept I have read the maintained page on this and I still have a gap, so I…
BWSANTIRSS+7 11 26k 9mo